{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:44:57Z","timestamp":1788896697064,"version":"build-2803163510"},"reference-count":20,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,23]]},"DOI":"10.31744\/einstein_journal\/2026ao1908","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:24:21Z","timestamp":1777051461000},"source":"Crossref","is-referenced-by-count":1,"title":["SR-B1 knockdown suppresses breast cancer cell proliferation, migration, and invasion via the PI3K\/AKT pathway"],"prefix":"10.31744","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1319-0542","authenticated-orcid":false,"given":"Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4705-1191","authenticated-orcid":false,"given":"Yanmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1620-3338","authenticated-orcid":false,"given":"Jinwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2990-6004","authenticated-orcid":false,"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"issue":"10","key":"key20260424172417_B1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102569","article-title":"Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)","volume":"14","author":"Smolarz","year":"2022","unstructured":"1. Smolarz B, Nowak AZ, Romanowicz H. Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers (Basel). 2022;14(10):2569. Review.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"key20260424172417_B2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","article-title":"The lingering mysteries of metastatic recurrence in breast cancer","volume":"124","author":"Riggio","year":"2021","unstructured":"2. Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124(1):13-26.","journal-title":"Br J Cancer"},{"issue":"12","key":"key20260424172417_B3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126806","article-title":"Breast Cancer Metastasis: Mechanisms and Therapeutic Implications","volume":"23","author":"Park","year":"2022","unstructured":"3. Park M, Kim D, Ko S, Kim A, Mo K, Yoon H. Breast Cancer Metastasis: Mechanisms and Therapeutic Implications. Int J Mol Sci. 2022;23(12):6806.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"key20260424172417_B4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MOL.0000000000000413","article-title":"Rediscovering scavenger receptor type BI: surprising new roles for the HDL receptor","volume":"28","author":"Hoekstra","year":"2017","unstructured":"4. Hoekstra M, Sorci-Thomas M. Rediscovering scavenger receptor type BI: surprising new roles for the HDL receptor. Curr Opin Lipidol. 2017;28(3):255-60.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"key20260424172417_B5","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3761-z","article-title":"Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma","volume":"18","author":"Xu","year":"2018","unstructured":"5. Xu GH, Lou N, Shi HC, Xu YC, Ruan HL, Xiao W, et al. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. BMC Cancer. 2018;18(1):88.","journal-title":"BMC Cancer"},{"issue":"4","key":"key20260424172417_B6","first-page":"4604","article-title":"Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness","volume":"15","author":"Wang","year":"2018","unstructured":"6. Wang X, Wu C, Yuan B, Wang D, Liu H, Feng H, et al. Low scavenger receptor class B type I expression is associated with gastric adenocarcinoma tumor aggressiveness. Oncol Lett. 2018;15(4):4604-10.","journal-title":"Oncol Lett"},{"issue":"6","key":"key20260424172417_B7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.prp.2016.03.011","article-title":"Up-regulated expression of scavenger receptor class B type 1 (SR-B1) is associated with malignant behaviors and poor prognosis of breast cancer","volume":"212","author":"Li","year":"2016","unstructured":"7. Li J, Wang J, Li M, Yin L, Li XA, Zhang TG. Up-regulated expression of scavenger receptor class B type 1 (SR-B1) is associated with malignant behaviors and poor prognosis of breast cancer. Pathol Res Pract. 2016;212(6):555-9.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"key20260424172417_B8","article-title":"Prognostic and clinicopathological significance of SR-B1 in solid tumors: A meta-analysis","volume":"216","author":"Wang","year":"2020","unstructured":"8. Wang M, Chao C, Luo G, Wang B, Zhan X, Di D, et al. Prognostic and clinicopathological significance of SR-B1 in solid tumors: A meta-analysis. Pathol Res Pract. 2020;216(4):152849.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"key20260424172417_B9","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1158\/0008-5472.CAN-03-0675","article-title":"A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells","volume":"64","author":"Cao","year":"2004","unstructured":"9. Cao WM, Murao K, Imachi H, Yu X, Abe H, Yamauchi A, et al. A mutant high-density lipoprotein receptor inhibits proliferation of human breast cancer cells. Cancer Res. 2004;64(4):1515-21.","journal-title":"Cancer Res"},{"key":"key20260424172417_B10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","unstructured":"10. Qian S, Wei Z, Yang W, Huang J, Yang Y, Wang J. The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front Oncol. 2022;12:985363.","journal-title":"Front Oncol"},{"issue":"2","key":"key20260424172417_B11","first-page":"783","article-title":"PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia","volume":"19","author":"Xie","year":"2019","unstructured":"11. Xie Y, Shi X, Sheng K, Han G, Li W, Zhao Q, et al. PI3K\/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia. Mol Med Rep. 2019;19(2):783-91. Review.","journal-title":"Mol Med Rep"},{"issue":"3","key":"key20260424172417_B12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","unstructured":"12. Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20(3):175-93.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"key20260424172417_B13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/dc12-0194","article-title":"Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration","volume":"36","author":"Tinahones","year":"2013","unstructured":"13. Tinahones FJ, Co\u00edn Arag\u00fcez L, Murri M, Oliva Olivera W, Mayas Torres MD, Barbarroja N, et al. Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration. Diabetes Care. 2013;36(3):513-21.","journal-title":"Diabetes Care"},{"issue":"1","key":"key20260424172417_B14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCRESAHA.112.280081","article-title":"Scavenger receptor class B type I is a plasma membrane cholesterol sensor","volume":"112","author":"Saddar","year":"2013","unstructured":"14. Saddar S, Carriere V, Lee WR, Tanigaki K, Yuhanna IS, Parathath S, et al. Scavenger receptor class B type I is a plasma membrane cholesterol sensor. Circ Res. 2013;112(1):140-51.","journal-title":"Circ Res"},{"issue":"1","key":"key20260424172417_B15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-physiol-021317-121550","article-title":"SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux","volume":"80","author":"Shen","year":"2018","unstructured":"15. Shen WJ, Azhar S, Kraemer FB. SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux. Annu Rev Physiol. 2018;80(1):95-116.","journal-title":"Annu Rev Physiol"},{"key":"key20260424172417_B16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00466","article-title":"Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging","volume":"7","author":"Mooberry","year":"2016","unstructured":"16. Mooberry LK, Sabnis NA, Panchoo M, Nagarajan B, Lacko AG. Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging. Front Pharmacol. 2016;7:466.","journal-title":"Front Pharmacol"},{"issue":"16","key":"key20260424172417_B17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163949","article-title":"The Pathogenic Role of PI3K\/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review","volume":"13","author":"Rascio","year":"2021","unstructured":"17. Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, et al. The Pathogenic Role of PI3K\/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review. Cancers (Basel). 2021;13(16):3949. Review.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"key20260424172417_B18","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","unstructured":"18. He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425.","journal-title":"Signal Transduct Target Ther"},{"key":"key20260424172417_B19","article-title":"PI3K\/Akt\/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?","volume":"12","author":"Peng","year":"2022","unstructured":"19. Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K\/Akt\/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Front Oncol. 2022;12:819128.","journal-title":"Front Oncol"},{"issue":"4","key":"key20260424172417_B20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1158\/2159-8290.CD-18-1175","article-title":"Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors","volume":"9","author":"Hanker","year":"2019","unstructured":"20. Hanker AB, Kaklamani V, Arteaga CL. Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors. Cancer Discov. 2019;9(4):482-91.","journal-title":"Cancer Discov"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T17:24:24Z","timestamp":1777051464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/sr-b1-knockdown-suppresses-breast-cancer-cell-proliferation-migration-and-invasion-via-the-pi3k-akt-pathway\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":20,"alternative-id":["10.31744\/einstein_journal\/2026AO1908"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2026ao1908","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"eAO1908"}}